Seller comparison · US self-pay prices

Noom vs LillyDirect (Eli Lilly): GLP-1 Prices Compared

Noom and LillyDirect (Eli Lilly) do not sell the same product here: Noom sells compounded semaglutide injection ($279/28 days); LillyDirect (Eli Lilly) sells Foundayo pill (from $149/mo), Zepbound injection ($299-$449/28 days), Trulicity injection (from $389/28 days), and Mounjaro injection (from $499/28 days). What each sells here: Noom, compounded GLP-1s only; LillyDirect (Eli Lilly), FDA-approved brand-name GLP-1s only. Compounded GLP-1s are not FDA-approved. Prices checked Nov 4, 2026.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices

Each seller's lowest price now

  • Lowest price, compounded and not FDA-approved

    Noom

    $279/28 days · about $299 per 30 days

  • Lowest price, FDA-approved

    LillyDirect (Eli Lilly)

    from $149/mo · about $149 per 30 days

Different products

What Noom and LillyDirect (Eli Lilly) each sell

Noom
  • Compounded semaglutide injection

    Advertised entry price

    $279/28 days

    28-day supply · 3-month upfront payment required (noom.com)

    ≈ $298.93 per 30 days at this quoted rate

    Checked

    Compounded semaglutide via Noom Med

    Noom · Sourced provider quote

    after $129 for the first 4-week supply; billed $837 every 12 weeks; medication (if prescribed), clinician visits, coaching and the Noom program included

    Price conditions

    after $129 for the first 4-week supply; billed $837 every 12 weeks; medication (if prescribed), clinician visits, coaching and the Noom program included

    Noom states $279/month, billed as $837 for 12 weeks; an FAQ on the same page still says $249/mo on the recurring 12-week plan. Cancel anytime. Not available in Alabama, Louisiana or Mississippi. Compounded; not FDA-approved.

    28-day supply · 3-month upfront payment required

LillyDirect (Eli Lilly)
  • Foundayo pill

    Advertised entry price

    from $149/mo

    30-day supply (lilly.com)

    $149 per 30 days at this quoted rate

    Checked

    Foundayo (LillyDirect self-pay)

    LillyDirect (Eli Lilly) · Manufacturer direct

    self-pay cash, lowest dose; ~$25/mo with commercial coverage through the savings card, which ends Dec 31, 2026

    Price conditions

    self-pay cash, lowest dose; ~$25/mo with commercial coverage through the savings card, which ends Dec 31, 2026

    LillyDirect self-pay ladder, each a 30-day supply: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.

    30-day supply

    Published maintenance dose

    $299/mo

    30-day supply (lilly.com)

    $299 per 30 days at this quoted rate

    Checked

    At 17.2 mg

    Foundayo (LillyDirect self-pay)

    LillyDirect (Eli Lilly) · Manufacturer direct

    Published price at 17.2 mg

    Price conditions

    Published price at 17.2 mg

    LillyDirect self-pay ladder, each a 30-day supply: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.

    Self-Pay Journey price for 14.5 mg and 17.2 mg with a refill within 45 days; regular price $349. Eligibility, additional taxes and fees may apply.

    30-day supply

  • Zepbound injection

    Advertised entry price

    $299-$449/28 days

    28-day supply (zepbound.lilly.com)

    ≈ $320.36 per 30 days at this quoted rate

    Checked

    Zepbound KwikPen (multi-dose pen)

    LillyDirect (Eli Lilly) · Manufacturer direct

    self-pay cash, by dose ($299 / $399 / $449)

    Price conditions

    self-pay cash, by dose ($299 / $399 / $449)

    Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.

    28-day supply

    Published maintenance dose

    $449/28 days

    28-day supply (zepbound.lilly.com)

    ≈ $481.07 per 30 days at this quoted rate

    Checked

    At 15 mg

    Zepbound KwikPen (multi-dose pen)

    LillyDirect (Eli Lilly) · Manufacturer direct

    Published price at 15 mg

    Price conditions

    Published price at 15 mg

    Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.

    Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).

    28-day supply

  • Trulicity injection

    Advertised entry price

    from $389/28 days

    28-day supply (lilly.com)

    ≈ $416.79 per 30 days at this quoted rate

    Checked

    Trulicity single-dose pens

    LillyDirect (Eli Lilly) · Manufacturer direct

    self-pay, four weekly pens; published starting rate at each dose

    Price conditions

    self-pay, four weekly pens; published starting rate at each dose

    The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

    28-day supply

    Published maintenance dose

    from $389/28 days

    28-day supply (lilly.com)

    ≈ $416.79 per 30 days at this quoted rate

    Checked

    At 4.5 mg

    Trulicity single-dose pens

    LillyDirect (Eli Lilly) · Manufacturer direct

    Published price at 4.5 mg

    Price conditions

    Published price at 4.5 mg

    The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

    The same starting rate is published for 0.75, 1.5, 3 and 4.5 mg. Taxes and additional fees may apply.

    28-day supply

  • Mounjaro injection

    Advertised entry price

    from $499/28 days

    28-day supply (lilly.com)

    ≈ $534.64 per 30 days at this quoted rate

    Checked

    Mounjaro single-dose pens

    LillyDirect (Eli Lilly) · Manufacturer direct

    self-pay, four weekly pens; published starting rate at each dose

    Price conditions

    self-pay, four weekly pens; published starting rate at each dose

    The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

    28-day supply

    Published maintenance dose

    from $499/28 days

    28-day supply (lilly.com)

    ≈ $534.64 per 30 days at this quoted rate

    Checked

    At 15 mg

    Mounjaro single-dose pens

    LillyDirect (Eli Lilly) · Manufacturer direct

    Published price at 15 mg

    Price conditions

    Published price at 15 mg

    The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

    The same starting rate is published for all six strengths, 2.5-15 mg. Taxes and additional fees may apply.

    28-day supply

Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss

Every sourced offer

All Noom and LillyDirect (Eli Lilly) offers

Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.

8 offers · US self-pay

  • Foundayo (LillyDirect self-pay)

    Orforglipron · Manufacturer direct

    Advertised pricefrom $149/mo

    30-day supply (lilly.com)

    Checked

    Maintenance price$299/mo

    At 17.2 mg

    30-day supply (lilly.com)

    Checked

    View offer
    Price conditions & source

    Advertised price: self-pay cash, lowest dose; ~$25/mo with commercial coverage through the savings card, which ends Dec 31, 2026

    Maintenance terms: Self-Pay Journey price for 14.5 mg and 17.2 mg with a refill within 45 days; regular price $349. Eligibility, additional taxes and fees may apply.

    LillyDirect self-pay ladder, each a 30-day supply: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (lilly.com)
  • Compounded semaglutide via Noom Med

    Semaglutide · Compounded

    Compounded · Not FDA-approved
    Advertised price$279/28 days

    28-day supply · 3-month upfront payment required (noom.com)

    ≈ $298.93 per 30 days

    Checked

    Maintenance price

    No separate dose price verified

    View offer
    Price conditions & source

    Advertised price: after $129 for the first 4-week supply; billed $837 every 12 weeks; medication (if prescribed), clinician visits, coaching and the Noom program included

    Noom states $279/month, billed as $837 for 12 weeks; an FAQ on the same page still says $249/mo on the recurring 12-week plan. Cancel anytime. Not available in Alabama, Louisiana or Mississippi. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (noom.com)
  • Zepbound KwikPen (multi-dose pen)

    Tirzepatide · Manufacturer direct

    Advertised price$299-$449/28 days

    28-day supply (zepbound.lilly.com)

    ≈ $320.36 per 30 days

    Checked

    Maintenance price$449/28 days

    At 15 mg

    28-day supply (zepbound.lilly.com)

    ≈ $481.07 per 30 days

    Checked

    View offer
    Price conditions & source

    Advertised price: self-pay cash, by dose ($299 / $399 / $449)

    Maintenance terms: Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).

    Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (zepbound.lilly.com)
  • Zepbound single-dose vials (2.5 mg)

    Tirzepatide · Manufacturer direct

    Advertised price$299/28 days

    28-day supply (zepbound.lilly.com)

    ≈ $320.36 per 30 days

    Checked

    Maintenance price$449/28 days

    At 15 mg

    28-day supply (zepbound.lilly.com)

    ≈ $481.07 per 30 days

    Checked

    View offer
    Price conditions & source

    Advertised price: self-pay cash, starting dose

    Maintenance terms: Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).

    Self-pay only, available exclusively through LillyDirect Pharmacy. Lilly states that 2.5 mg starts treatment and is not a maintenance dose.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (zepbound.lilly.com)
  • Trulicity single-dose pens

    Dulaglutide · Manufacturer direct

    Advertised pricefrom $389/28 days

    28-day supply (lilly.com)

    ≈ $416.79 per 30 days

    Checked

    Maintenance pricefrom $389/28 days

    At 4.5 mg

    28-day supply (lilly.com)

    ≈ $416.79 per 30 days

    Checked

    View offer
    Price conditions & source

    Advertised price: self-pay, four weekly pens; published starting rate at each dose

    Maintenance terms: The same starting rate is published for 0.75, 1.5, 3 and 4.5 mg. Taxes and additional fees may apply.

    The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (lilly.com)
  • Zepbound single-dose vials (5 mg)

    Tirzepatide · Manufacturer direct

    Advertised price$399/28 days

    28-day supply (zepbound.lilly.com)

    ≈ $427.50 per 30 days

    Checked

    Maintenance price$449/28 days

    At 15 mg

    28-day supply (zepbound.lilly.com)

    ≈ $481.07 per 30 days

    Checked

    View offer
    Price conditions & source

    Advertised price: self-pay cash

    Maintenance terms: Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).

    Self-pay only, available exclusively through LillyDirect Pharmacy.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (zepbound.lilly.com)
  • Zepbound single-dose vials (7.5-15 mg)

    Tirzepatide · Manufacturer direct

    Advertised price$449/28 days

    28-day supply (zepbound.lilly.com)

    ≈ $481.07 per 30 days

    Checked

    Maintenance price$449/28 days

    At 15 mg

    28-day supply (zepbound.lilly.com)

    ≈ $481.07 per 30 days

    Checked

    View offer
    Price conditions & source

    Advertised price: self-pay cash, higher doses

    Maintenance terms: Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).

    The $449 rate is the Self Pay Journey Program price and holds only with a refill within 45 days; miss the window and the higher doses revert to the regular single-dose vial price of $499 (7.5 mg) or $699 (10 mg, 12.5 mg, and 15 mg).

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (zepbound.lilly.com)
  • Mounjaro single-dose pens

    Tirzepatide · Manufacturer direct

    Advertised pricefrom $499/28 days

    28-day supply (lilly.com)

    ≈ $534.64 per 30 days

    Checked

    Maintenance pricefrom $499/28 days

    At 15 mg

    28-day supply (lilly.com)

    ≈ $534.64 per 30 days

    Checked

    View offer
    Price conditions & source

    Advertised price: self-pay, four weekly pens; published starting rate at each dose

    Maintenance terms: The same starting rate is published for all six strengths, 2.5-15 mg. Taxes and additional fees may apply.

    The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (lilly.com)

Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.

Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.

The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of October 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.

Public record

Noom vs LillyDirect (Eli Lilly): reviews, BBB and FDA

What Trustpilot, the BBB and the FDA say about each. These records do not measure medical quality or results.

Noom

Trustpilot 4.5 from 67,221 reviews. The BBB rates Noom A+, with 597 complaints filed in the last 3 years. It is BBB accredited. We found no FDA warning letter naming Noom as of Nov 6, 2026.

Is Noom legit?
Questions

Noom vs LillyDirect (Eli Lilly): common questions

Is Noom or LillyDirect (Eli Lilly) cheaper for GLP-1 medication?

They do not sell the same product here, so neither is cheaper for the same medication. Only Noom: Compounded semaglutide injection $279/28 days. Only LillyDirect (Eli Lilly): Foundayo pill from $149/mo; Zepbound injection $299-$449/28 days; Trulicity injection from $389/28 days; Mounjaro injection from $499/28 days.

Do Noom and LillyDirect (Eli Lilly) sell FDA-approved GLP-1s or compounded versions?

What each sells here: Noom, compounded GLP-1s only; LillyDirect (Eli Lilly), FDA-approved brand-name GLP-1s only. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.

What do Noom and LillyDirect (Eli Lilly) prices include?

Noom, compounded semaglutide injection: $279/28 days, after $129 for the first 4-week supply; billed $837 every 12 weeks; medication (if prescribed), clinician visits, coaching and the Noom program included. LillyDirect (Eli Lilly), Foundayo pill: from $149/mo, self-pay cash, lowest dose; ~$25/mo with commercial coverage through the savings card, which ends Dec 31, 2026. LillyDirect (Eli Lilly), Zepbound injection: $299-$449/28 days, self-pay cash, by dose ($299 / $399 / $449). LillyDirect (Eli Lilly), Trulicity injection: from $389/28 days, self-pay, four weekly pens; published starting rate at each dose. LillyDirect (Eli Lilly), Mounjaro injection: from $499/28 days, self-pay, four weekly pens; published starting rate at each dose.

When were Noom and LillyDirect (Eli Lilly) prices last checked?

Prices checked Nov 4, 2026. Each quote links the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

Seller pages re-read automatically : 1 of 5 opened and checked for price changes. How prices stay current

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.